Clinical Topics

Adherence to New Medications Is Critical for Veterans With Diabetes

by U.S. Medicine

August 19, 2018

KNOXVILLE, TN—How important is adherence to oral medications in reducing complications for veterans with diabetes?

A new study published in Diabetic Medicine looked at the relationship of following drug regimens to macrovascular and microvascular complications, time to insulin therapy, revascularization, admissions and death among veterans with uncomplicated diabetes.1

The retrospective cohort study was led by researchers from the University of Tennessee School of Pharmacy and included input from VAMCs in Nashville and Memphis. The study team used the VA Corporate Data Warehouse to examine 159,032 veterans diagnosed with uncomplicated diabetes during 2002–2014 and starting oral anti-diabetes therapy for the first time.

Researchers identified and confirmed the first uncomplicated diabetes diagnosis by subsequent oral anti-diabetes therapy initiation. To calculate adherence, they used outpatient pharmacy records including the proportion of days covered over the first year of therapy. Health outcomes were observed up to five years beyond the first oral anti-diabetes dispensation and analyzed with adjustments for baseline demographic and clinical characteristics.

Results indicated that, during the first five years of oral anti-diabetes treatment, people initially non‐adherent to oral anti-diabetes therapy were more likely to experience myocardial infarction (hazard ratio 1.14, 95% CI 1.03-1.27) and ischemic stroke (hazard ratio 1.22, 95% CI 1.05-0.1.42), or to die (hazard ratio 1.21; 95% CI 1.15-1.28).

In fact, veterans with less than 20% adherence in the first year had particularly high hazards for ischemic stroke (hazard ratio 1.78, 95% CI 1.27-2.49) and all‐cause death (hazard ratio 1.33, 95% CI 1.17-151), study authors pointed out. Patients who were adherence, however, were more likely to be diagnosed with a microvascular complication or chronic kidney disease.

“People who are non‐adherent to treatment were more likely to experience detrimental health outcomes within the first five years of anti-diabetes therapy,” study authors concluded. “Adherence is paramount to disease management and this should be stressed from the time at which treatment is initiated.”

1. Gatwood JD, Chisholm-Burns M, Davis R, Thomas F, Potukuchi P, Hung A, Kovesdy CP. Differences in health outcomes associated with initial adherence to oral antidiabetes medications among veterans with uncomplicated Type 2 diabetes: a 5-year survival analysis. Diabet Med. 2018 Jul 6. doi: 10.1111/dme.13775. [Epub ahead of print] PubMed PMID: 29978496.

Comments are closed here.

Related Articles

VA Overall Appointment Wait Times Shorter than the Private-Sector

Despite intense scrutiny of wait times for veterans seeking VA care over the last three years, a new study pointed out that delays in the private sector weren’t statistically less in 2014 and that, possibly because of the focus, wait times now are significantly shorter for the VA compared to private-sector healthcare facilities.

Senate Blocks Agent Orange Exposure Extension to Blue Water Veterans

Blue Water Navy veterans who claim to be impacted by toxic exposure while serving off the coast of Vietnam were forced to grapple with disappointment once again as the 115th Congress ended without passing legislation addressing their VA benefits.

U.S. Medicine Recommends

More From diabetes


Is Prandial Insulin or Noninsulin Agent Better for T2D Treatment Intensification?

Some veterans with type 2 diabetes patients can't reach their hemoglobin A1c goal despite using metformin, basal insulin and a sulfonylurea. What should come next?


Caution Urged in Use of Sulfonylureas in Some T2 Diabetes Patients with CAD

VA clinicians should exercise caution with use of sulfonylurea in some patients with co-morbid type 2 diabetes and cardiovascular disease, according to new research.


Hypoglycemia Concerns Help Drive Use of Continuous Glucose Monitoring at VA

As the VA increases its focus on minimizing hypoglycemia in veterans with type 2 diabetes, it expects that more physicians and veterans will consider using continuous glucose monitors to meet that goal.


Cautious Use of Prandial Insulin Urged for Older Veterans

A new VA study pointed out why prandial insulin should be used cautiously in older adults with complex comorbidities.


VA Research Links Global Air Pollution to Diabetes Risk

Air pollution, even at levels technically falling into safe ranges, are associated with an increased risk of diabetes, according to a new study involving VA researchers.

Subscribe to U.S. Medicine Print Magazine

U.S. Medicine is mailed free each month to physicians, pharmacists, nurse practitioners, physician assistants and administrators working for Veterans Affairs, Department of Defense and U.S. Public Health Service.

Subscribe Now

Receive Our Email Newsletter

Stay informed about federal medical news, clinical updates and reports on government topics for the federal healthcare professional.

Sign Up